In addition, HUWE1 inhibition by the inhibitors BI8622 and BI8626 reduced the proliferation of MM cells, and HUWE1 inhibition promoted the antitumor effects of conventional MM therapies. Here, HUWE1 is linked to Miyoshi myopathy.